Bill Title: To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes.

Sponsorship: Partisan Bill (Republican 19)

Status: (Introduced) 2025-01-23 - Referred to the House Committee on Energy and Commerce. [HB679 Detail]

---

Bill Drafts

Revision	Date	Format	Source	View
Introduced	2025-02-21	PDF	Link	View

Amendments

Amendment	Date	Disposition	Format	Source	View
No bill amendments currently on file for US Congress HB679

Supplemental Documents

Title	Description	Date	Format	Source	View
No supplemental documents for US Congress HB679 currently on file.